HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82.

Abstract
Epidermal growth factor receptor (EGFR) gene mutations are strongly associated with lung adenocarcinoma and favorable response to EGFR tyrosine kinase inhibitor. The mutated EGFR proteins (EGFRs) are hyper-phosphorylated and refractory to receptor down-regulation. To address the discrepancy between hyper-phosphorylation and lack of down-regulation of mutant EGFRs, we have examined the expression of EGFR negative regulators in non-small cell lung cancer (NSCLC) cell lines. We found that NSCLC cell lines expressing mutant EGFRs often had low expression of various negative regulators for EGFR. Among them, tumor suppressor CD82 was up-regulated by wild type (WT) EGFR but down-regulated by mutant EGFRs. Reconstitution of CD82 exerted stronger suppressive effects on mutant EGFRs than on WT EGFR. Active exportation of CD82 through the exosome was one of the mechanisms involved in achieving the overall CD82 down-regulation in mutant EGFR-expressing lung cancer cell lines. Over-expression of mutant EGFR protein frequently occurred in the lung cancer tissues of mutant EGFR-transgenic mice and also associated with CD82 down-regulation. Immunoblot analyses on the tumor tissues from 23 lung adenocarcinoma patients (12 with WT EGFR, and 11 with mutant EGFRs) also identified significantly stronger down-regulation of CD82 in tumors with mutant EGFRs than WT. Our data indicate that CD82 down-regulation could be a critical step involved in the EGFR over-expression and the stronger tumorigenic activity triggered by EGFR mutations. Up-regulation of the CD82 level may become a promising new treatment strategy for lung adenocarcinoma.
AuthorsChi-Hwa Yang, Hsiao-Chin Chou, Yu-Ning Fu, Chi-Ling Yeh, Hui-Wen Cheng, Il-Chi Chang, Ko-Jiunn Liu, Gee-Chen Chang, Ting-Fen Tsai, Shih-Feng Tsai, Hui-Ping Liu, Yi-Cheng Wu, Ya-Ting Chen, Shiu-Feng Huang, Yi-Rong Chen
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1852 Issue 7 Pg. 1540-9 (Jul 2015) ISSN: 0006-3002 [Print] Netherlands
PMID25912735 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015. Published by Elsevier B.V.
Chemical References
  • Kangai-1 Protein
  • ErbB Receptors
Topics
  • Adenocarcinoma (genetics, metabolism)
  • Adenocarcinoma of Lung
  • Animals
  • Carcinoma, Non-Small-Cell Lung (genetics, metabolism)
  • Cell Line, Tumor
  • ErbB Receptors (genetics, metabolism)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Kangai-1 Protein (genetics, metabolism)
  • Lung Neoplasms (genetics, metabolism)
  • Mice
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: